Company Filing History:
Years Active: 1986
Title: Hanns-Gerd Dammann: A Trailblazer in Cytoprotective Innovations
Introduction: Hanns-Gerd Dammann is a notable inventor based in Hamburg, Germany. With a background in the pharmaceutical industry, he has made significant contributions through his innovative work. Dammann currently holds one patent, demonstrating his commitment to advancing medical science.
Latest Patents: Dammann's patent focuses on 13-thiaprostaglandins with cytoprotective activity. This innovative compound, detailed in patent claims, includes formulas such as 13-thiaprostaglandins of Formula I, where B can be either --CH2--CH2-- or --CH═CH--. This advancement holds potential for improving therapeutic applications in various medical fields.
Career Highlights: Hanns-Gerd Dammann is affiliated with Merck Patent Gesellschaft mit beschränkter Haftung, a well-respected organization in the pharmaceutical sector. His role within the company has allowed him to develop and refine innovative solutions that address specific medical challenges.
Collaborations: Throughout his career, Dammann has collaborated with esteemed colleagues such as Bernd Simon and Peter Muller. These partnerships reflect the collaborative spirit common in the fields of research and development, promoting innovation through shared insights and expertise.
Conclusion: Hanns-Gerd Dammann's contributions to the field of cytoprotective agents signify the important role inventors play in shaping our understanding of medical treatments. With his patented work and collaborative projects, he continues to inspire future innovations in the pharmaceutical industry.